心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06609 心玮医疗-B

未开盘 07-22 16:08:02

46.560

+5.340

+12.95%

最高48.000	最低44.300	成交量25.53万
今开44.300	昨收41.220	日振幅8.98%
总市值18.09亿	流通市值14.24亿	总股本3,886万
成交额1,193万	换手率0.83%	流通股本3,059万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06609","market":"HK","secType":"STK","nameCN":"心玮医疗-B","latestPrice":46.56,"timestamp":1784707682156,"preClose":41.22,"halted":0,"volume":255250,"delay":0,"changeRate":0.12954876273653576,"floatShares":30593400,"shares":38862000,"eps":2.5461263408820023,"marketStatus":"未开盘","change":5.34,"latestTime":"07-22 16:08:02","open":44.3,"high":48,"low":44.3,"amount":11929195,"amplitude":0.089762,"askPrice":47.2,"askSize":1900,"bidPrice":46.56,"bidSize":200,"shortable":0,"etf":0,"ttmEps":2.5461263408820023,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784770200000},"marketStatusCode":0,"adr":0,"listingDate":1629388800000,"exchange":"SEHK","adjPreClose":41.22,"openAndCloseTimeList":[[1784683800000,1784692800000],[1784696400000,1784707200000]],"volumeRatio":6.291595,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06609","defaultTab":"news","newsList":[{"id":"2653382827","title":"心玮医疗-B午前涨超14% 上半年经调整利润预计翻倍增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2653382827","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653382827?lang=zh_cn&edition=full","pubTime":"2026-07-22 11:26","pubTimestamp":1784690760,"startTime":"0","endTime":"0","summary":"　　心玮医疗-B盘中涨超16%，截至发稿，股价上涨14.17%，现报47.06港元，成交额850.08万港元。　　7月21日，心玮医疗发布2026年中期盈利预告。公司预期2026年上半年实现收益不低于2.8亿元，同比增长超50.9%；净利润不低于6000万元；经调整净利润不低于7000万元，同比增长至少104.7%，盈利能力进一步提升。经调整净利润增长主要由于高毛利产品的营收贡献提高，导致整体毛利率较去年同期有所提升；及营运效率提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-22/doc-iniirwqf2102435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1587","06609","BK1574","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653787575","title":"港股异动 | 心玮医疗-B(06609.HK)涨超10% 上半年经调整利润预计翻倍增长 核心业务持续突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2653787575","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653787575?lang=zh_cn&edition=full","pubTime":"2026-07-22 09:47","pubTimestamp":1784684824,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","06609","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653782059","title":"港股异动丨心玮医疗大涨超16%，中期业绩亮眼，经调整净利同比增超100%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653782059","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653782059?lang=zh_cn&edition=full","pubTime":"2026-07-22 09:46","pubTimestamp":1784684767,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["06609","BK1587","BK1574","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141765323","title":"心玮医疗-B预计上半年营收不低于2.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141765323","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141765323?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:20","pubTimestamp":1784647236,"startTime":"0","endTime":"0","summary":"心玮医疗-B（06609.HK）发布业绩预告，预计截至2026年6月30日的六个月期间，公司营收将不低于人民币2.8亿元。同时，公司预计同期净利润将不低于人民币6000万元。\n此次业绩预告显示了公司业务的稳健发展态势。营收与净利润的预期表现，反映了其在医疗技术领域的市场竞争力与运营效率。公司将继续专注于心血管介入医疗器械的研发与商业化，以巩固和提升其市场地位。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609","BK1587","BK1574","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653208818","title":"心玮医疗(06609)发布2026年中期盈利预告，收入利润高增长，业绩表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2653208818","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653208818?lang=zh_cn&edition=full","pubTime":"2026-07-21 21:04","pubTimestamp":1784639088,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2026年7月21日，上海心玮医疗科技股份有限公司发布2026年中期盈利预告。经调整净利润同比增长超100%，盈利能力持续改善，运营效率不断提升报告期内，公司持续推进业务结构升级，从以通路产品驱动的1.0阶段迈向以创新治疗产品引领的2.0阶段，高价值创新产品收入贡献持续提升，带动整体毛利率较去年同期有所改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06609","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163821182","title":"心玮医疗-B发布正面盈利预告：上半年收入预计不少于2.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163821182","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163821182?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:51","pubTimestamp":1784638310,"startTime":"0","endTime":"0","summary":"心玮医疗-B7月21日晚间披露正面盈利预告，公司预计截至2026年6月30日止六个月实现收入不少于2.8亿元，较2025年同期的1.855亿元增长至少50.9%。同期，公司预期实现净利润不少于60百万元，高于去年同期的50.9百万元；经调整净利润预计不少于70百万元，较去年同期的34.2百万元增幅至少104.7%。公司指出，相关数据基于董事会对集团管理账目的初步评估，未经独立核数师或审计委员会审核，最终未经审计中期业绩预计将于2026年8月底公布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653827061","title":"心玮医疗-B(06609)发盈喜 预期上半年经调整净利润不低于7000万元 同比增长至少104.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653827061","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653827061?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:50","pubTimestamp":1784638228,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B 公布，该集团预期于2026年上半年实现收益不低于2.8亿元，同比增长至少50.9%;净利润不低于6000万元，2025年同期净利为5090万元;经调整净利润不低于7000万元，同比增长至少 104.7%。经调整净利润增长主要由于高毛利产品的营收贡献提高，导致整体毛利率较去年同期有所提升;及营运效率提升，销售及分销开支和行政开支得到有效控制。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"心玮医疗-B(06609)发盈喜 预期上半年经调整净利润不低于7000万元 同比增长至少104.7%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160020086","title":"心玮医疗-B预计2026年上半年净利润不低于6000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1160020086","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160020086?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:48","pubTimestamp":1784638090,"startTime":"0","endTime":"0","summary":"上海心玮医疗科技股份有限公司发布业绩预告，预计截至2026年6月30日止的六个月内，归属于公司所有者的净利润将不低于人民币6000万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609","BK1574","BK1100","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650580902","title":"脑机接口板块走高 南京熊猫电子股份(00553)涨7.95% 机构指行业仍将迎来持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2650580902","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650580902?lang=zh_cn&edition=full","pubTime":"2026-07-10 13:48","pubTimestamp":1783662519,"startTime":"0","endTime":"0","summary":"金吾财讯 | 脑机接口板块走高，南京熊猫电子股份 涨7.95%，联想集团涨4.66%，心玮医疗-B涨1.75%，脑动极光-B涨0.56%，微创脑科学涨0.22%。短中期来看，行业仍将迎来持续催化，包括非侵入式商业化情况、侵入式注册临床进展、行业临床规范和医保支付体系的完善以及Pre-IPO/IPO带来的市场情绪，此外Neuralink的关键临床节点也将持续掀起行业关注热度。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985606","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0049112450.USD","LU0052756011.USD","LU0672654166.SGD","80992","BK1189","LU0128525689.USD","LU0320764755.SGD","LU0862451753.SGD","MNTL","HK0000320223.HKD","02172","BK1149","06681","LU0029875118.USD","LU0791591158.USD","IE0034224299.USD","LU0543330483.HKD","BK1574","LU1366334651.USD","HK0000320264.USD","LU0572939691.SGD","LU0791590937.USD","LU0128522157.USD","LU1267930227.SGD","LU1366334578.USD","IE0032431581.USD","BK1526","LU0862451837.USD","BK1607","IE00B0JY6N72.USD","BK1587","LNVGY","LU0264606111.USD","HK0000306701.USD","06609","LU0572940350.SGD","LU1235295612.USD","BK1100","LU0310800965.SGD","00992","BK1193","LU2242644610.SGD","LU1046422090.SGD","IBRN","TCHI","00553","HK0000306685.HKD","LU0890818403.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118341198","title":"心玮医疗-B批准H股回购计划，最高斥资1亿港元回购最多100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1118341198","media":"投资观察","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118341198?lang=zh_cn&edition=full","pubTime":"2026-07-03 19:13","pubTimestamp":1783077225,"startTime":"0","endTime":"0","summary":"上海心玮医疗科技股份有限公司（06609.HK）于6月29日宣布，其董事会已批准一项H股回购计划。根据该计划，公司拟动用不超过1亿港元的资金，在公开市场上回购不超过100万股H股。\n此项回购计划旨在优化公司资本结构，提升每股收益，并彰显管理层对公司未来长期发展前景的信心。市场分析认为，此举有助于向投资者传递积极信号，并可能对股价形成支撑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1587","BK1574","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158953629","title":"心玮医疗-B发布2026年6月股份变动月报表，非上市股增至8,268,604股","url":"https://stock-news.laohu8.com/highlight/detail?id=1158953629","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158953629?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:15","pubTimestamp":1782983754,"startTime":"0","endTime":"0","summary":"2026年7月2日，上海心瑋醫療科技股份有限公司披露了截至2026年6月30日的股份变动月报表。公告显示，公司注册股本由上月末的人民币31,565,804元（H股）及人民币7,268,604元合计人民币38,834,408元，增加至报告期末的人民币39,834,408元。与此同时，公司的非上市股（普通股）由上月底的7,268,604股增加至8,268,604股，新增1,000,000股内资股，认购价格为每股45港元。上述新增股份已获得公司股东大会及类别股东大会批准。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198145995","title":"心玮医疗-B发行100万股非上市股份，涉资约4,500.00万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198145995","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198145995?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:26","pubTimestamp":1782743174,"startTime":"0","endTime":"0","summary":"心玮医疗-B (06609)于2026年6月29日发布公告，董事会批准发行1,000,000股非上市股份，每股认购价格45港元，涉资约4,500.00万港元。根据公告，本次发行股份数量占原有7,268,604股非上市股份的约13.76%。\n发行完成后，公司非上市股份由7,268,604股增至8,268,604股；H股方面与公司库藏股数保持不变，分别为30,593,404股与972,400股，合计31,565,804股。公司公告同时确认已遵守香港联合交易所有限公司证券上市规则及相关法律规定。\n本次公告由董事王国辉签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"心玮医疗-B发行100万股非上市股份，涉资约4,500.00万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647337774","title":"心玮医疗-B(06609.HK)拟回购不超过1亿港元的H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647337774","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647337774?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:16","pubTimestamp":1782742572,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1587","BK1100","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647377708","title":"心玮医疗-B(06609.HK)完成发行100万股内资股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647377708","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647377708?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:15","pubTimestamp":1782742528,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","06609","BK1100","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168962977","title":"心玮医疗-B批准H股回购计划 斥资最高1亿港元购回最多100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1168962977","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168962977?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:15","pubTimestamp":1782742518,"startTime":"0","endTime":"0","summary":"上海心玮医疗科技股份有限公司（心玮医疗-B）董事会已批准一项H股回购计划。根据该计划，公司获授权动用不超过1亿港元资金，在公开市场购回最多100万股H股。\n此项回购计划旨在优化公司资本结构，提升每股收益，并彰显管理层对公司未来发展的信心。回购行动将在符合香港联合交易所有限公司证券上市规则及相关法律法规的前提下进行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609","BK1587","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642281428","title":"心玮医疗-B(06609)：丁魁辞任非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2642281428","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642281428?lang=zh_cn&edition=full","pubTime":"2026-06-10 19:09","pubTimestamp":1781089786,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B(06609)发布公告，丁魁先生因其他个人事务已辞任非执行董事、董事会审计委员会及董事会战略委员会成员职务，自2026年6月10日起生效。独立非执行董事郭少牧先生于丁先生辞任后已获委任为审计委员会成员。其任期将于当前第二届董事会任期届满为止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1587","06609","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162599471","title":"心玮医疗-B2026年5月股份变动月报：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1162599471","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162599471?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:43","pubTimestamp":1780476194,"startTime":"0","endTime":"0","summary":"上海心瑋醫療科技股份有限公司于2026年6月3日发布2026年5月股份变动月报表。公告显示，截至2026年5月31日，公司已发行普通股合计共38,834,408股，包括H股31,565,804股及非上市股7,268,604股，注册股本与上月持平。截至5月底，心玮医疗-B已符合香港联交所相关公众持股量要求。公告由公司董事王国辉于2026年6月3日签署，公司确认将继续遵守香港联交所《上市规则》及相关法律法规的要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640827269","title":"脑机接口概念股走高 蓝思科技(06613)涨7.48% 机构指5月商保覆盖标志行业向普惠化、商业化迈进","url":"https://stock-news.laohu8.com/highlight/detail?id=2640827269","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640827269?lang=zh_cn&edition=full","pubTime":"2026-06-01 10:15","pubTimestamp":1780280113,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股脑机接口概念股全线走高，截至发稿，联想集团 涨10.08%，蓝思科技涨7.48%，心玮医疗-B涨3.52%，南京熊猫电子股份涨2.02%，微创脑科学涨1.41%。该机构认为：从2025年3月医保局为脑机接口收费立项到2026年5月商保覆盖，脑机接口支付端已经实现从手术费到耗材支出全链路打通，脑机接口真正向普惠化、商业化迈进。基于此，该机构认为，随着商业保险覆盖，行业正实现商业闭环，投融资底层逻辑已从前瞻性技术布局转向高确定性的产业投资。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1982615","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B0JY6N72.USD","HK0000306701.USD","02172","BK0028","LU0791590937.USD","BK1149","LU1366334578.USD","HK0000320223.HKD","LU0049112450.USD","LU2242644610.SGD","LU1046422090.SGD","BK0076","LU0310800965.SGD","IE0034224299.USD","LU0572940350.SGD","LU0128525689.USD","06609","00553","BK1526","HK0000320264.USD","SGXZ81163826.USD","LU1235295612.USD","SGXZ49509284.SGD","BK0196","BK0072","BK1170","LU0052756011.USD","BK1193","06613","LU1267930227.SGD","BK1607","300433","00992","LU0264606111.USD","LU0791591158.USD","HK0000306685.HKD","LU1979443071.USD","BK0201","LU1934453819.USD","BK0214","BK0064","IE0032431581.USD","BK1574","LNVGY","LU0572939691.SGD","80992","BK1100","LU1366334651.USD","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637387783","title":"心玮医疗-B(06609)根据特别授权认购新内资股获中国证监会同意注册的批复","url":"https://stock-news.laohu8.com/highlight/detail?id=2637387783","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637387783?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:54","pubTimestamp":1779360890,"startTime":"0","endTime":"0","summary":"四、 自中国证监会同意注册之日起至本次发行结束前，本公司如发生重大事项，应及时报告中国证监会并按有关规定处理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心玮医疗-B(06609)根据特别授权认购新内资股获中国证监会同意注册的批复","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1100","BK1587","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636002633","title":"港股概念追踪 | 国内首次！128通道全植入式脑机接口开启临床试验，脑机接口产业落地有望提速(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636002633","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636002633?lang=zh_cn&edition=full","pubTime":"2026-05-19 07:46","pubTimestamp":1779147991,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月18日，我国正式启动首个128通道全植入式脑机接口系统多中心临床试验，这项试验由首都医科大学附属北京天坛医院担任组长单位，标志着我国自主研发的全侵入式脑机接口技术加速进入临床转化阶段。据悉，此次研究采用的侵入式脑机接口系统，由皮层内植入式柔性电极与高集成度全植入式信号采集器两大模块构成。团队将完成128通道系统的安全性和有效性验证。本次临床试验将为更高阶的脑机接口技术积累关键数据。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/f98cd56d60416e16704eeca3f233a320","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/f98cd56d60416e16704eeca3f233a320"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443199.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","00553","BK1587","BK4588","06609","VXUS","02172","BK1149","06613","BK4585","BK1100","BK1170"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.strokemedical.com","stockEarnings":[{"period":"1week","weight":0.0945},{"period":"1month","weight":0.0992},{"period":"3month","weight":-0.1931},{"period":"6month","weight":-0.1874},{"period":"1year","weight":-0.0459},{"period":"ytd","weight":-0.133}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0473},{"period":"3month","weight":-0.0395},{"period":"6month","weight":-0.0694},{"period":"1year","weight":-0.0094},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海心玮医疗科技股份有限公司是一家主要从事医疗器械研发、生产和商业化的中国公司。该公司的主要神经介入产品及在研产品包括缺血性脑卒中取栓器械，如Captor取栓器械和颅内血栓抽吸导管，颅内动脉狭窄治疗器械，如颅内球囊扩张导管及颈动脉球囊扩张导管和栓塞保护系统，出血性脑卒中治疗器械，如颅内动脉瘤栓塞辅助支架和血流导向装置，缺血性脑卒中预防器械，如左心耳封堵器，以及血管通路器械如远端通路导管、微导管、封堵球囊导管等。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.1064},{"month":2,"riseRate":0.4,"avgChangeRate":-0.067342},{"month":3,"riseRate":0.4,"avgChangeRate":-0.0145},{"month":4,"riseRate":0.4,"avgChangeRate":-0.01346},{"month":5,"riseRate":0.2,"avgChangeRate":-0.061255},{"month":6,"riseRate":0.4,"avgChangeRate":0.043804},{"month":7,"riseRate":0.6,"avgChangeRate":0.081961},{"month":8,"riseRate":0.5,"avgChangeRate":-0.063767},{"month":9,"riseRate":0.6,"avgChangeRate":0.057771},{"month":10,"riseRate":0.4,"avgChangeRate":-0.058186},{"month":11,"riseRate":0.4,"avgChangeRate":0.057501},{"month":12,"riseRate":0.8,"avgChangeRate":0.076512}],"exchange":"SEHK","name":"心玮医疗-B","nameEN":"HEARTCARE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心玮医疗-B(06609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心玮医疗-B,06609,心玮医疗-B股票,心玮医疗-B股票老虎,心玮医疗-B股票老虎国际,心玮医疗-B行情,心玮医疗-B股票行情,心玮医疗-B股价,心玮医疗-B股市,心玮医疗-B股票价格,心玮医疗-B股票交易,心玮医疗-B股票购买,心玮医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心玮医疗-B(06609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}